Journal-News: UC researchers engineer bacteria to weaken cancer cell walls
University of Cincinnati researchers in the James L. Winkle College of Pharmacy have developed a new probiotic bacteria designed to break down cancer cell walls and give therapies an easier way in to kill tumors.
Nalinikanth Kotagiri, PhD, the senior author of this study, an assistant professor in UC’s James L. Winkle College of Pharmacy and a UC Cancer Center member, said the bacteria naturally targets tumor cells, as bacteria prefer low-oxygen and immunodeficient environments.
“There’s bacteria in the gut, on the skin, inside your lungs, inside your mouth, even inside tumors,” Kotagiri said. “So why not take advantage of that and find interesting ways to make them a bit more proactive?”
Read the Journal-News article.
Featured photo at top of Dr. Kotagiri working in his lab. Photo/Colleen Kelley/University of Cincinnati.
Related Stories
Clean Earth Rovers cofounders named to Forbes 30 Under 30 list
November 30, 2023
A pair of graduates of the University of Cincinnati’s Venture Lab program were recognized as being among the top entrepreneurs in North America as part of the 2024 Forbes 30 Under 30 list. Clean Earth Rovers cofounders Michael Arens and David Constantine were named to the 13th annual Forbes 30 Under 30 list in the energy category.
CNN Business: Best Buy’s simple strategy for beating shoplifting
November 30, 2023
The Best Buy approach to thwart shoplifting is to increase staffing. It's a move that UC criminologist John Eck says, in a CNN Business article, that makes perfect sense. It's also a different approach at a time when most retailers are reducing staff.
CCM Dance presents 'An American in Paris + Other Works' on Nov....
November 28, 2023
CCM Dance proudly presents An American in Paris + Other Works, a lively program featuring repertoire ranging from classical ballet to modern dance. The centerpiece of the program is An American in Paris, a one-act ballet set to George Gershwin’s iconic music, choreographed by guest artist Peter Davison.